PathwayTMB: A pathway-based tumor mutational burden analysis method for predicting the clinical outcome of cancer immunotherapy

Immunotherapy has become one of the most promising therapy methods for cancer, but only a small number of patients are responsive to it, indicating that more effective biomarkers are urgently needed. This study developed a pathway analysis method, named PathwayTMB, to identify genomic mutation pathw...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiangmei, He, Yalan, Jiang, Ying, Pan, Bingyue, Wu, Jiashuo, Zhao, Xilong, Huang, Junling, Wang, Qian, Cheng, Liang, Han, Junwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514137/
https://www.ncbi.nlm.nih.gov/pubmed/37744173
http://dx.doi.org/10.1016/j.omtn.2023.09.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514137/
https://www.ncbi.nlm.nih.gov/pubmed/37744173
http://dx.doi.org/10.1016/j.omtn.2023.09.003

Ejemplares similares